Malaria vaccines

Two malaria vaccines are recommended by WHO for programmatic use in children living in P. falciparum malaria–endemic areas: RTS,S/AS01 (Mosquirix) and R21/Matrix-M. ^{Go to footnote 11} Both vaccines have WHO prequalification. ^{Go to footnote 22, Go to footnote 33, Go to footnote 44}  

Detailed information on the available products can be found in the vaccine comparison table, including licensing, presentation, formulation, dosage and route of administration. ^{Go to footnote 55}

The malaria vaccination series for each child should be completed with the same product whenever feasible. However, if the product used for a prior dose is unavailable or unknown, the series should be completed with either of the available WHO-recommended malaria vaccines. Restarting the vaccine series is not recommended. ^{Go to footnote 11}